NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Gynoveda

Gynoveda

Private
MumbaiHealthcare & Life Scienceshttps://gynoveda.com/

Last Round

Series A

Mar 15, 2023

Est. Valuation

$30.88M

Total Funding Raised

$12M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Gynoveda is an ayurvedic FemTech company that provides natural, tech-enabled healthcare solutions for women's reproductive and menstrual health.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Telemedicine, E-commerce, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Keywords

Ayurvedic medicineFemTechwomen's healthPCOS treatmentinfertility treatmentmenstrual healthD2C brandAyurvedic fertility clinicsreproductive healthphygital healthcaretelemedicineonline doctor consultationAyurvedic supplementsnatural fertility treatmentirregular periodsAI diagnosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gynoveda Comparables

Compare Gynoveda with similar companies based on industry and business-model similarity.

Gynoveda comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Gynoveda Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 15, 2023
SeedNov 19, 2019
SeedOct 1, 2019

Gynoveda Investors

Notable investors and investment history

Gynoveda investors
InvestorRounds
Alteria CapitalSeries A
Fireside VenturesSeries A, Seed
RPG VenturesSeries A
India Alternatives Investment AdvisorsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Job posting reveals goal to triple revenue by 2026.

  • Oct 1, 2025

    Plans to grow from 50 to 200 clinics in 24 months.

Gynoveda Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gynoveda Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gynoveda's valuation, stock price, and market status.

Firmographic Details

HeadquartersMumbai
Employee Range341
Year Founded2019
Last FundingMar 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.